CEL-SCI
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CEL-SCI and other ETFs, options, and stocks.About CVM
CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS).
CEOGeert R. Kersten
CEOGeert R. Kersten
Employees—
Employees—
HeadquartersVienna, Virginia
HeadquartersVienna, Virginia
Founded1983
Founded1983
Employees—
Employees—
CVM Key Statistics
Market cap29.20M
Market cap29.20M
Price-Earnings ratio-0.64
Price-Earnings ratio-0.64
Dividend yield—
Dividend yield—
Average volume116.76K
Average volume116.76K
High today$1.69
High today$1.69
Low today$1.51
Low today$1.51
Open price$1.53
Open price$1.53
Volume267.19K
Volume267.19K
52 Week high$10.83
52 Week high$10.83
52 Week low$0.89
52 Week low$0.89
Stock Snapshot
CEL-SCI(CVM) stock is priced at $1.65, giving the company a market capitalization of 29.2M. It carries a P/E multiple of -0.64.
On 2026-09-20, CEL-SCI(CVM) stock moved within a range of $1.51 to $1.69. With shares now at $1.65, the stock is trading +9.3% above its intraday low and -2.4% below the session's peak.
Trading volume for CEL-SCI(CVM) stock has reached 267.19K, versus its average volume of 116.76K.
The stock's 52-week range extends from a low of $0.89 to a high of $10.83.
The stock's 52-week range extends from a low of $0.89 to a high of $10.83.
CVM News
TipRanks 5d
CEL-SCI to deliver keynote at Otorhinolaryngology 2026 - TipRanks...
People also own
Based on the portfolios of people who own CVM. This list is generated using Robinhood data, and it’s not a recommendation.